Robert A Nathan1, Philip J Thompson2, David Price3, Leonardo M Fabbri4, Sundeep Salvi5, Sandra González-Díaz6, Jorge F Maspero7, Jorge J Moreno-Cantu8, James E Fish9, Kevin Murphy10. 1. Asthma & Allergy Associates, P.C. and Research Center, Colorado Springs, Colo. Electronic address: DrRNathan@aol.com. 2. Centre for Asthma, Allergy and Respiratory Research, University of Western Australia, Nedlands, Western Australia. 3. Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Aberdeen, United Kingdom. 4. Department of Oncology Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy. 5. Chest Research Foundation Marigold Complex, Kalyaninagar, Pune, India. 6. Centro Regional de Alergia e Inmunología Clínica, Hospital Universitario Dr. José Eleuterio González, Facultad de Medicina UANL, Monterrey, Nuevo León, Mexico. 7. Fundacion CIDEA Allergy and Respiratory Research Unit, Buenos Aires, Argentina. 8. Merck & Co., Inc., Whitehouse Station, NJ. 9. Gladwyne, Pa. 10. Boystown National Research Hospital, Boys Town, Neb.
Abstract
BACKGROUND: Asthma, a worldwide health problem, can be controlled if properly diagnosed and managed. Multinational surveys conducted in patients with asthma from 1998 to 2003 indicated that asthma was inadequately controlled. The Asthma Insight and Management (AIM) study represents the largest survey conducted on patients with asthma since 2003. OBJECTIVE: The objective of this study was to assess findings from the United States (US), Europe and Canada (EUCAN), Latin America (LA), and the Asia-Pacific (AP) region surveys to identify differences and similarities with earlier surveys on patients with asthma. METHODS: The US, EUCAN, LA, and AP AIM surveys conducted from 2009 to 2011 all used a common set of questions. Responses to these are reported as proportions of patients with asthma for each country individually, and as totals for all regions. Results are presented as mean/median proportions for US, EUCAN, LA, and AP survey populations individually. Global medians and the range of regional response values are also described. RESULTS: A total of 10,302 patients or parents of adolescents with asthma were interviewed. Approximately one-quarter reported daytime symptoms daily or on most days over the previous 4 weeks. Globally, a median of 67% (range, 27%-88%) of patients perceived their asthma as completely and/or well controlled, but a median of only 9% (range, 0%-29%) of patients had well-controlled asthma using criteria from asthma guidelines. A majority (≥60%) of patients felt that quick-relief medication could be used daily if needed, contrary to guideline recommendations. CONCLUSIONS: Patients exhibited a lack of knowledge and conviction for treatment recommendations and guidelines that was relatively uniform across the regions, similar to earlier survey findings. These results reveal an ongoing need for improvement in asthma care and education in most populations.
BACKGROUND:Asthma, a worldwide health problem, can be controlled if properly diagnosed and managed. Multinational surveys conducted in patients with asthma from 1998 to 2003 indicated that asthma was inadequately controlled. The Asthma Insight and Management (AIM) study represents the largest survey conducted on patients with asthma since 2003. OBJECTIVE: The objective of this study was to assess findings from the United States (US), Europe and Canada (EUCAN), Latin America (LA), and the Asia-Pacific (AP) region surveys to identify differences and similarities with earlier surveys on patients with asthma. METHODS: The US, EUCAN, LA, and AP AIM surveys conducted from 2009 to 2011 all used a common set of questions. Responses to these are reported as proportions of patients with asthma for each country individually, and as totals for all regions. Results are presented as mean/median proportions for US, EUCAN, LA, and AP survey populations individually. Global medians and the range of regional response values are also described. RESULTS: A total of 10,302 patients or parents of adolescents with asthma were interviewed. Approximately one-quarter reported daytime symptoms daily or on most days over the previous 4 weeks. Globally, a median of 67% (range, 27%-88%) of patients perceived their asthma as completely and/or well controlled, but a median of only 9% (range, 0%-29%) of patients had well-controlled asthma using criteria from asthma guidelines. A majority (≥60%) of patients felt that quick-relief medication could be used daily if needed, contrary to guideline recommendations. CONCLUSIONS:Patients exhibited a lack of knowledge and conviction for treatment recommendations and guidelines that was relatively uniform across the regions, similar to earlier survey findings. These results reveal an ongoing need for improvement in asthma care and education in most populations.
Authors: Erick Forno; Diego D Brandenburg; Jose A Castro-Rodriguez; Carlos A Celis-Preciado; Fernando Holguin; Christopher Licskai; Stephanie Lovinsky-Desir; Marcia Pizzichini; Alejandro Teper; Connie Yang; Juan C Celedón Journal: Ann Am Thorac Soc Date: 2022-04
Authors: Eric D Bateman; David B Price; Hao-Chien Wang; Adel Khattab; Patricia Schonffeldt; Angelina Catanzariti; Ralf J P van der Valk; Maarten J H I Beekman Journal: Eur Respir J Date: 2022-05-05 Impact factor: 33.795